R01 Fund LP
Insider CIK 1990517 · NBY Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SDEV Stablecoin Development Cor | X Exercise deriv | 2026-06-15 | 2026-06-17 | 11,332,020 | — | $0 | 0 | SEC↗ |
| SDEV Stablecoin Development Cor | X Exercise | 2026-06-15 | 2026-06-17 | 11,332,020 | — | $0 | 22,693,236 | SEC↗ |
| SDEV Stablecoin Development Cor | S Sale | 2026-06-15 | 2026-06-17 | 24,720 | $1.09 | $26.9K | 22,668,516 | SEC↗ |
| SDEV Stablecoin Development Cor | P Buy deriv | 2026-01-16 | 2026-05-19 | 53,679,974 | $0.85 | $45.63M | 53,679,974 | SEC↗ |
| SDEV Stablecoin Development Cor | C Conversion | 2025-10-21 | 2026-04-30 | 11,361,216 | — | $0 | 11,361,216 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | C Conversion | 2025-10-21 | 2025-11-03 | 56,806,080 | — | $0 | 56,806,080 | SEC↗ |
| SDEV Stablecoin Development Cor | P Buy deriv | 2025-10-16 | 2026-04-30 | 11,332,020 | — | $0 | 11,332,020 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2025-10-16 | 2025-10-20 | 134,375 | — | $0 | 134,375 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2025-10-16 | 2025-10-20 | 220,663 | — | $0 | 220,663 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy deriv | 2025-10-16 | 2025-11-03 | 2,702,703 | — | $0 | 2,702,703 | SEC↗ |